Publication:
Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function

dc.contributor.authorCurriu, Marta
dc.contributor.authorFausther-Bovendo, Hughes
dc.contributor.authorPernas, Maria
dc.contributor.authorMassanella, Marta
dc.contributor.authorCarrillo, Jorge
dc.contributor.authorCabrera, Cecilia
dc.contributor.authorLopez-Galindez, Luis Cecilio
dc.contributor.authorClotet, Bonaventura
dc.contributor.authorDebré, Patrice
dc.contributor.authorVieillard, Vincent
dc.contributor.authorBlanco, Julià
dc.contributor.funderRed de Investigación Cooperativa en Investigación en Sida (España)
dc.contributor.funderFundación para la Investigación y la Prevención del Sida en España
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderGovernment of Catalonia (España)
dc.date.accessioned2018-11-20T12:17:15Z
dc.date.available2018-11-20T12:17:15Z
dc.date.issued2012-02
dc.description.abstractBACKGROUND: CD4 T-cell decay is variable among HIV-infected individuals. In exceptional cases, CD4 T-cell counts remain stable despite high plasma viremia. HIV envelope glycoprotein (Env) properties, namely tropism, fusion or the ability to induce the NK ligand NKp44L, or host factors that modulate Env cytopathic mechanisms may be modified in such situation. METHODS: We identified untreated HIV-infected individuals showing non-cytopathic replication (VL>10,000 copies/mL and CD4 T-cell decay<50 cells/µL/year, Viremic Non Progressors, VNP) or rapid progression (CD4 T-cells<350 cells/µL within three years post-infection, RP). We isolated full-length Env clones and analyzed their functions (tropism, fusion activity and capacity to induce NKp44L expression on CD4 cells). Anti-Env humoral responses were also analyzed. RESULTS: Env clones isolated from VNP or RP individuals showed no major phenotypic differences. The percentage of functional clones was similar in both groups. All clones tested were CCR5-tropic and showed comparable expression and fusogenic activity. Moreover, no differences were observed in their capacity to induce NKp44L expression on CD4 T cells from healthy donors through the 3S epitope of gp41. In contrast, anti- Env antibodies showed clear functional differences: plasma from VNPs had significantly higher capacity than RPs to block NKp44L induction by autologous viruses. Consistently, CD4 T-cells isolated from VNPs showed undetectable NKp44L expression and specific antibodies against a variable region flanking the highly conserved 3S epitope were identified in plasma samples from these patients. Conversely, despite continuous antigen stimulation, VNPs were unable to mount a broad neutralizing response against HIV. CONCLUSIONS: Env functions (fusion and induction of NKp44L) were similar in viremic patients with slow or rapid progression to AIDS. However, differences in humoral responses against gp41 epitopes nearby 3S sequence may contribute to the lack of CD4 T cell decay in VNPs by blocking the induction of NKp44L by gp41.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipFunding: Spanish AIDS network ‘Red Temática Cooperativa de Investigación en SIDA’, RIS, RD06/0006 (to JB, CLG, MP and MC). “Fundacion para la Investigacion y Prevencion del SIDA en España” FIPSE grant 08/36725 (to CC). Health Department of the Catalan Government (Generalitat de Catalunya) and Instituto de Salud Carlos III (contracts CP04/00271 and CES98/3047 to CC and JB, respectively). Instituto de Salud Carlos III (contract CD09/00150 to JC). Work in CNM is supported by grant SAF 2007-61036 and SAF 2010-17226 and by FIPSE grants 36558/06, 36641/07, 36779/08, 360766/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.format.number2es_ES
dc.format.pagee30330es_ES
dc.format.volume7es_ES
dc.identifier.citationPLoS One. 2012;7(2):e30330es_ES
dc.identifier.doi10.1371/journal.pone.0030330es_ES
dc.identifier.e-issn1932-6203es_ES
dc.identifier.issn1932-6203es_ES
dc.identifier.journalPloS onees_ES
dc.identifier.pubmedID22312424es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/6639
dc.language.isoenges_ES
dc.publisherPublic Library of Science (PLOS)
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0030330es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAmino Acid Sequencees_ES
dc.subject.meshCD4 Lymphocyte Countes_ES
dc.subject.meshCD4-Positive T-Lymphocyteses_ES
dc.subject.meshEpitopeses_ES
dc.subject.meshHIV Antibodieses_ES
dc.subject.meshHIV Envelope Protein gp41es_ES
dc.subject.meshHIV Infectionses_ES
dc.subject.meshHIV-1es_ES
dc.subject.meshHumanses_ES
dc.subject.meshImmunity, Humorales_ES
dc.subject.meshMolecular Sequence Dataes_ES
dc.subject.meshNatural Cytotoxicity Triggering Receptor 2es_ES
dc.subject.meshTime Factorses_ES
dc.subject.meshViral Tropismes_ES
dc.subject.meshViremiaes_ES
dc.subject.meshVirus Internalizationes_ES
dc.subject.meshAntibody Specificityes_ES
dc.titleViremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and functiones_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationcca7e901-0913-4b71-8c9d-ee7dd20b6458
relation.isAuthorOfPublicationf57c2687-907b-44ea-a780-7920ff8b9b41
relation.isAuthorOfPublication.latestForDiscoverycca7e901-0913-4b71-8c9d-ee7dd20b6458
relation.isFunderOfPublicationbd66462f-7c35-4da3-bc87-24070e0fdd55
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationc6fbffec-abb4-4f0e-81e0-3b254d5dd85d
relation.isFunderOfPublication.latestForDiscoverybd66462f-7c35-4da3-bc87-24070e0fdd55
relation.isPublisherOfPublicationa2759e3d-0d58-4e8a-9fcd-c6130ee333d1
relation.isPublisherOfPublication.latestForDiscoverya2759e3d-0d58-4e8a-9fcd-c6130ee333d1

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ViremicHIVInfectedIndividuals_2012.pdf
Size:
940.39 KB
Format:
Adobe Portable Document Format
Description: